FDA Panel Endorses New Alzheimer’s Drug After Accelerated Approval
The newest Alzheimer’s drug is on its way for full regulatory approval after a U.S. Food and Drug Administration (FDA) advisory panel voted that the drug was beneficial in slowing cognitive decline. The drug is expected to be fully approved by July 6, 2023.1 In clinical trials the drug, known as lecanemab, demonstrated a 27 […]
Twelve Infants Die During Clinical Trials for FDA-Endorsed RSV Drug
On June 8, 2023, the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted unanimously (21-0) in favor of AstraZeneca and Sanofi’s new nirsevimab (Beyfortus) monoclonal antibody drug believed to provide protection for infants from respiratory syncytial virus (RSV) disease and other lower respiratory tract infections during their first year of life.1 […]
More Women Bearing the Brunt of COVID Vaccine Reactions and Injury
Early reports to the Vaccine Adverse Event Reporting System (VAERS), a centralized federally operated vaccine reaction reporting system, after the messenger RNA (mRNA) COVID-19 shots were distributed under an Emergency Use Authorization (EUA in the United States revealed that women were reported to have experienced more severe allergic reactions to the COVID-19 shots than men. […]
U.S. Government Pockets $400 Million from Moderna mRNA COVID Shots
A recently disclosed contract reveals that the U.S. government received millions of dollars in licensing fees from Moderna, Inc. The company paid the National Institutes of Health (NIH) $400 million to use NIH’s spike protein technology in Moderna’s Spikevax messenger RNA (mRNA) COVID-19 biologic.1 2 The large payment was part of a royalty-bearing license agreement […]
Birth Rates Plummet in Countries Most Heavily Vaccinated Against COVID-19
A team of European researchers have determined that birth rates in 19 European countries declined sharply toward the end of 2021 following peak COVID-19 vaccine uptake earlier that year in the spring. The research, compiled in August 2022, found that decreased birth rate patterns persisted all of the countries represented in the data, including Germany, […]
Big Pharma’s Influence on U.S. Medical Schools is Significant
An informal survey of medical schools conducted in 2005 by National Public Radio (NPR) showed that a number of universities and academic institutions are funded by pharmaceutical giants and other health industry sources. The survey, carried out through telephone calls and internet searches, found that two to six percent of the yearly budget of medical […]